Cresco Labs (CRLBF) Free Cash Flow (2019 - 2026)
Cresco Labs' (CRLBF) quarterly Free Cash Flow came in at $7.6 million in Q1 2026, up 31.28% YoY from $5.8 million in Q1 2025, and up 122.58% on a QoQ basis from -$33.8 million in Q4 2025.
Cresco Labs (CRLBF) Free Cash Flow (2019 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 8 years of Free Cash Flow data on file, last reported at $7.6 million in Q1 2026.
- Quarterly Free Cash Flow rose 31.28% year-over-year to $7.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $278000.0 (down 99.67% YoY) and the FY2025 annual result came in at $37.8 million, down 71.4% from the prior year.
- Free Cash Flow rose to $7.6 million in Q1 2026, from -$33.8 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $55.4 million in Q3 2024 to a low of -$149.3 million in Q4 2022.
- A 5-year average of $741176.5 and a median of $12.7 million in 2024 frame the typical range for Free Cash Flow.
- The widest YoY moves for Free Cash Flow: up 800.96% in 2025, down 366.19% in 2025.
- Tracing CRLBF's Free Cash Flow over 5 years: stood at -$149.3 million in 2022, then climbed by 26.82% to -$109.3 million in 2023, then jumped by 111.63% to $12.7 million in 2024, then plunged by 366.19% to -$33.8 million in 2025, then jumped by 122.58% to $7.6 million in 2026.
- The last three Free Cash Flow figures came in at $7.6 million (Q1 2026), -$33.8 million (Q4 2025), and $13.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Cresco Labs | 295.09 Mn | 230.98 Mn | 86.95 Mn | 9.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.64 Mn |
| Mar 31, 2026 | 7.64 Mn |
| Dec 31, 2025 | -33.83 Mn |
| Dec 31, 2025 | -33.83 Mn |
| Sep 30, 2025 | 13.34 Mn |
| Sep 30, 2025 | 13.34 Mn |
| Jun 30, 2025 | 13.12 Mn |
| Jun 30, 2025 | 13.12 Mn |
| Mar 31, 2025 | 5.82 Mn |
| Mar 31, 2025 | 5.82 Mn |
| Dec 31, 2024 | 12.71 Mn |
| Dec 31, 2024 | 12.71 Mn |
| Sep 30, 2024 | 55.44 Mn |
| Sep 30, 2024 | 55.44 Mn |
| Jun 30, 2024 | 11.05 Mn |
| Jun 30, 2024 | 11.05 Mn |
| Mar 31, 2024 | -830,000.00 |
| Mar 31, 2024 | -830,000.00 |
| Dec 31, 2023 | -109.25 Mn |
| Dec 31, 2023 | -109.25 Mn |